Regulation & law · 29/08/2007

Tessarae Inc. to Receive Exclusive Patent License from US Department of the Navy

The US Department of the Navy has announced its intention to grant Tessarae Inc. a non-exclusive, revocable license to utilize high-density resequencing microarrays for disease screening, diagnosis, and surveillance in the US and certain foreign countries, based on patented Navy technology.